Limits...
TSC22D4 is a molecular output of hepatic wasting metabolism.

Jones A, Friedrich K, Rohm M, Schäfer M, Algire C, Kulozik P, Seibert O, Müller-Decker K, Sijmonsma T, Strzoda D, Sticht C, Gretz N, Dallinga-Thie GM, Leuchs B, Kögl M, Stremmel W, Diaz MB, Herzig S - EMBO Mol Med (2013)

Bottom Line: In mammals, proper storage and distribution of lipids in and between tissues is essential for the maintenance of energy homeostasis.As a molecular cachexia output pathway, hepatic levels of the transcription factor transforming growth factor beta 1-stimulated clone (TSC) 22 D4 were increased in cancer cachexia.Therefore, hepatic TSC22D4 activity may represent a molecular rationale for peripheral energy deprivation in subjects with metabolic wasting diseases, including cancer cachexia.

View Article: PubMed Central - PubMed

Affiliation: Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance, Network Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University, Heidelberg, Germany.

Show MeSH

Related in: MedlinePlus

TSC22D4 overexpression reduces serum VLDL triglyceridesWestern blot of liver extracts from representative empty control or Flag-TSC22D4 cDNA adenovirus-injected C57Bl/6 mice 7 days after injection using FLAG and VCP antibodies (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in mice injected with empty control or TSC22D4 cDNA adenovirus in the fed or 16 h fasted state (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in high fat diet (HFD) fed mice injected with empty control or TSC22D4 cDNA adenovirus (means ± SEM, n ≥ 3).Liver TG levels of HFD or control diet (LFD) fed mice (means ± SEM, n ≥ 3, Two Way ANOVA; Holm–Sidak post hoc).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3569644&req=5

fig05: TSC22D4 overexpression reduces serum VLDL triglyceridesWestern blot of liver extracts from representative empty control or Flag-TSC22D4 cDNA adenovirus-injected C57Bl/6 mice 7 days after injection using FLAG and VCP antibodies (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in mice injected with empty control or TSC22D4 cDNA adenovirus in the fed or 16 h fasted state (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in high fat diet (HFD) fed mice injected with empty control or TSC22D4 cDNA adenovirus (means ± SEM, n ≥ 3).Liver TG levels of HFD or control diet (LFD) fed mice (means ± SEM, n ≥ 3, Two Way ANOVA; Holm–Sidak post hoc).

Mentions: Given the substantial upregulation of TSC22D4 under conditions of energy wasting (Fig 3B and F), we next sought to test the effects of TSC22D4 overexpression (Fig 5A) on systemic lipid handling. To this end, we employed wild-type mice with adenovirus-mediated liver-specific overexpression of TSC22D4 in a fasting-feeding regimen. In line with the results from TSC22D4 loss-of-function experiments (Fig. 4), overexpression of TSC22D4 led to a substantial reduction of VLDL-associated serum TG levels, particularly under fasting conditions (Fig 5B), leaving other metabolic parameters mostly unaltered (Supporting Information Fig S4A–F). To next explore whether TSC22D4 over-activation could potentially even counteract hyper-triglyceridemia as associated with energy surplus, mice were placed on a high-fat diet (60% calories from fat vs. 10% calories from fat) for 12 weeks and then injected with an adenovirus carrying the TSC22D4 cDNA. Consistent with the results from acute TSC22D4 loss- and gain-of-function data, overexpression of TSC22D4 (Supporting Information Fig S4G) was sufficient to substantially reduce serum levels of VLDL-associated TG (Fig 5C) and tended to induce hepatic lipid accumulation (Fig 5D), even in livers of overweight mice, while leaving other metabolic parameters generally unaltered (Supporting Information Fig S4H–L). Together, these data underline the notion that hepatic TSC22D4 fulfils a critical and specific checkpoint function for the regulation of circulating VLDL-TG and hepatic TG load, and that high TSC22D4 levels induce serum TG depletion and hypobetalipoproteinemia under both normal and high caloric intake conditions.


TSC22D4 is a molecular output of hepatic wasting metabolism.

Jones A, Friedrich K, Rohm M, Schäfer M, Algire C, Kulozik P, Seibert O, Müller-Decker K, Sijmonsma T, Strzoda D, Sticht C, Gretz N, Dallinga-Thie GM, Leuchs B, Kögl M, Stremmel W, Diaz MB, Herzig S - EMBO Mol Med (2013)

TSC22D4 overexpression reduces serum VLDL triglyceridesWestern blot of liver extracts from representative empty control or Flag-TSC22D4 cDNA adenovirus-injected C57Bl/6 mice 7 days after injection using FLAG and VCP antibodies (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in mice injected with empty control or TSC22D4 cDNA adenovirus in the fed or 16 h fasted state (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in high fat diet (HFD) fed mice injected with empty control or TSC22D4 cDNA adenovirus (means ± SEM, n ≥ 3).Liver TG levels of HFD or control diet (LFD) fed mice (means ± SEM, n ≥ 3, Two Way ANOVA; Holm–Sidak post hoc).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3569644&req=5

fig05: TSC22D4 overexpression reduces serum VLDL triglyceridesWestern blot of liver extracts from representative empty control or Flag-TSC22D4 cDNA adenovirus-injected C57Bl/6 mice 7 days after injection using FLAG and VCP antibodies (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in mice injected with empty control or TSC22D4 cDNA adenovirus in the fed or 16 h fasted state (means ± SEM, n ≥ 4).Lipoprotein-associated serum TG levels as measured by fast protein liquid chromatography (FPLC) in high fat diet (HFD) fed mice injected with empty control or TSC22D4 cDNA adenovirus (means ± SEM, n ≥ 3).Liver TG levels of HFD or control diet (LFD) fed mice (means ± SEM, n ≥ 3, Two Way ANOVA; Holm–Sidak post hoc).
Mentions: Given the substantial upregulation of TSC22D4 under conditions of energy wasting (Fig 3B and F), we next sought to test the effects of TSC22D4 overexpression (Fig 5A) on systemic lipid handling. To this end, we employed wild-type mice with adenovirus-mediated liver-specific overexpression of TSC22D4 in a fasting-feeding regimen. In line with the results from TSC22D4 loss-of-function experiments (Fig. 4), overexpression of TSC22D4 led to a substantial reduction of VLDL-associated serum TG levels, particularly under fasting conditions (Fig 5B), leaving other metabolic parameters mostly unaltered (Supporting Information Fig S4A–F). To next explore whether TSC22D4 over-activation could potentially even counteract hyper-triglyceridemia as associated with energy surplus, mice were placed on a high-fat diet (60% calories from fat vs. 10% calories from fat) for 12 weeks and then injected with an adenovirus carrying the TSC22D4 cDNA. Consistent with the results from acute TSC22D4 loss- and gain-of-function data, overexpression of TSC22D4 (Supporting Information Fig S4G) was sufficient to substantially reduce serum levels of VLDL-associated TG (Fig 5C) and tended to induce hepatic lipid accumulation (Fig 5D), even in livers of overweight mice, while leaving other metabolic parameters generally unaltered (Supporting Information Fig S4H–L). Together, these data underline the notion that hepatic TSC22D4 fulfils a critical and specific checkpoint function for the regulation of circulating VLDL-TG and hepatic TG load, and that high TSC22D4 levels induce serum TG depletion and hypobetalipoproteinemia under both normal and high caloric intake conditions.

Bottom Line: In mammals, proper storage and distribution of lipids in and between tissues is essential for the maintenance of energy homeostasis.As a molecular cachexia output pathway, hepatic levels of the transcription factor transforming growth factor beta 1-stimulated clone (TSC) 22 D4 were increased in cancer cachexia.Therefore, hepatic TSC22D4 activity may represent a molecular rationale for peripheral energy deprivation in subjects with metabolic wasting diseases, including cancer cachexia.

View Article: PubMed Central - PubMed

Affiliation: Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance, Network Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Center for Molecular Biology (ZMBH) and University Hospital, Heidelberg University, Heidelberg, Germany.

Show MeSH
Related in: MedlinePlus